Page last updated: 2024-09-04

liensinine and Dyslipidemia

liensinine has been researched along with Dyslipidemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Jiang, R; Liang, L; Meng, S; Ye, S; Zhou, J; Zhou, X	1

Other Studies

1 other study(ies) available for liensinine and Dyslipidemia

Article	Year
Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling. International immunopharmacology, 2022, Volume: 104 Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cytokines; Diet, High-Fat; Dyslipidemias; Hepatocytes; Humans; Hypolipidemic Agents; Isoquinolines; Lipid Metabolism; Liver; Male; MAP Kinase Kinase Kinases; Mice, Inbred C57BL; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Palmitic Acid; Phenols; Reactive Oxygen Species	2022

Article

Year

Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.

International immunopharmacology, 2022, Volume: 104

Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cytokines; Diet, High-Fat; Dyslipidemias; Hepatocytes; Humans; Hypolipidemic Agents; Isoquinolines; Lipid Metabolism; Liver; Male; MAP Kinase Kinase Kinases; Mice, Inbred C57BL; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Palmitic Acid; Phenols; Reactive Oxygen Species

2022